论文部分内容阅读
Acute ischemic stroke (AIS),as the third leading cause of death worldwide,is characterized by its high incidence,mortality rate,high incurred disability rate,and frequent reoccurrence.The neuroprotective effects of Ginkgo biloba extract (GBE) against several cerebral diseases have been reported in previous studies,but the underlying mechanisms of action are still unclear.Using a novel in vitro rat cortical capillary endothelial cellastrocyte-neuron network model,we investigated the neuroprotective effects of GBE and one of its important constituents,Ginkgolide B (GB),against oxygen-glucose deprivation/reoxygenation and glucose (OGD/R) injury.In this model,rat cortical capillary endothelial cells,astrocytes,and neurons were cocultured so that they could be synchronously observed in the same system.Pretreatment with GBE or GB increased the neuron cell viability,ameliorated cell injury,and inhibited the cell apoptotic rate through Bax and Bcl-2 expression regulation after OGD/R injury.Furthermore,GBE or GB pretreatment enhanced the transendotheliai electrical resistance of capillary endothelial monolayers,reduced the endothelial permeability coefficients for sodium fluorescein (Na-F),and increased the expression levels of tight junction proteins,namely,ZO-1 and occludin,in endothelial cells.Results demonstrated the preventive effects of GBE on neuronal cell death and enhancement of the function of brain capillary endothelial monolayers after OGD/R injury in vitro;thus,GBE could be used as an effective neuroprotective agent for AIS/reperfusion,with GB as one of its significant constituents.